Haemonetics HAE Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's cash provided by (used in) investing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's cash provided by (used in) investing activity, including discontinued operation?
- Haemonetics (HAE) reported cash provided by (used in) investing activity, including discontinued operation of -$86.61M in Q1 2026.
- What is the long-term trend for Haemonetics's cash provided by (used in) investing activity, including discontinued operation?
- Over 3 years (2022 to 2026), Haemonetics's cash provided by (used in) investing activity, including discontinued operation has grown at a 27.6% compound annual growth rate (CAGR), from -$86.35M to -$179.55M.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.